PortfoliosLab logoPortfoliosLab logo
APYX vs. AREC
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

APYX vs. AREC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Apyx Medical Corporation (APYX) and American Resources Corporation (AREC). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

APYX vs. AREC - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
APYX
Apyx Medical Corporation
5.43%121.52%-39.69%11.97%-81.75%78.06%-14.89%26.46%
AREC
American Resources Corporation
-2.42%145.54%-32.21%12.88%-26.67%-7.69%209.52%-93.37%

Fundamentals

Market Cap

APYX:

$155.58M

AREC:

$204.02M

EPS

APYX:

-$0.27

AREC:

-$0.48

PS Ratio

APYX:

2.92

AREC:

1.39K

Total Revenue (TTM)

APYX:

$52.10M

AREC:

$145.03K

Gross Profit (TTM)

APYX:

$33.04M

AREC:

$140.16K

EBITDA (TTM)

APYX:

-$5.09M

AREC:

-$22.47M

Returns By Period

In the year-to-date period, APYX achieves a 5.43% return, which is significantly higher than AREC's -2.42% return.


APYX

1D
3.07%
1M
12.84%
YTD
5.43%
6M
72.43%
1Y
169.34%
3Y*
8.61%
5Y*
-17.68%
10Y*

AREC

1D
8.04%
1M
-19.33%
YTD
-2.42%
6M
-10.37%
1Y
417.98%
3Y*
17.28%
5Y*
-8.61%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

APYX vs. AREC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

APYX
APYX Risk / Return Rank: 8888
Overall Rank
APYX Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
APYX Sortino Ratio Rank: 8888
Sortino Ratio Rank
APYX Omega Ratio Rank: 8383
Omega Ratio Rank
APYX Calmar Ratio Rank: 9494
Calmar Ratio Rank
APYX Martin Ratio Rank: 9191
Martin Ratio Rank

AREC
AREC Risk / Return Rank: 9393
Overall Rank
AREC Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
AREC Sortino Ratio Rank: 9595
Sortino Ratio Rank
AREC Omega Ratio Rank: 9090
Omega Ratio Rank
AREC Calmar Ratio Rank: 9595
Calmar Ratio Rank
AREC Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

APYX vs. AREC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Apyx Medical Corporation (APYX) and American Resources Corporation (AREC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


APYXARECDifference

Sharpe ratio

Return per unit of total volatility

1.65

2.55

-0.90

Sortino ratio

Return per unit of downside risk

2.64

3.52

-0.87

Omega ratio

Gain probability vs. loss probability

1.31

1.39

-0.07

Calmar ratio

Return relative to maximum drawdown

5.05

5.73

-0.68

Martin ratio

Return relative to average drawdown

11.31

9.74

+1.58

APYX vs. AREC - Sharpe Ratio Comparison

The current APYX Sharpe Ratio is 1.65, which is lower than the AREC Sharpe Ratio of 2.55. The chart below compares the historical Sharpe Ratios of APYX and AREC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


APYXARECDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.65

2.55

-0.90

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.18

-0.08

-0.10

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.09

0.08

-0.17

Correlation

The correlation between APYX and AREC is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

APYX vs. AREC - Dividend Comparison

Neither APYX nor AREC has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

APYX vs. AREC - Drawdown Comparison

The maximum APYX drawdown since its inception was -94.99%, roughly equal to the maximum AREC drawdown of -97.12%. Use the drawdown chart below to compare losses from any high point for APYX and AREC.


Loading graphics...

Drawdown Indicators


APYXARECDifference

Max Drawdown

Largest peak-to-trough decline

-94.99%

-97.12%

+2.13%

Max Drawdown (1Y)

Largest decline over 1 year

-32.17%

-68.72%

+36.55%

Max Drawdown (5Y)

Largest decline over 5 years

-94.99%

-89.94%

-5.05%

Current Drawdown

Current decline from peak

-78.79%

-82.71%

+3.92%

Average Drawdown

Average peak-to-trough decline

-56.43%

-79.64%

+23.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.25%

40.45%

-24.20%

Volatility

APYX vs. AREC - Volatility Comparison

Apyx Medical Corporation (APYX) has a higher volatility of 25.51% compared to American Resources Corporation (AREC) at 21.41%. This indicates that APYX's price experiences larger fluctuations and is considered to be riskier than AREC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


APYXARECDifference

Volatility (1M)

Calculated over the trailing 1-month period

25.51%

21.41%

+4.10%

Volatility (6M)

Calculated over the trailing 6-month period

55.45%

97.71%

-42.26%

Volatility (1Y)

Calculated over the trailing 1-year period

103.25%

165.48%

-62.23%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

98.94%

107.24%

-8.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

93.04%

746.33%

-653.29%

Financials

APYX vs. AREC - Financials Comparison

This section allows you to compare key financial metrics between Apyx Medical Corporation and American Resources Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
18.42M
50.17K
(APYX) Total Revenue
(AREC) Total Revenue
Values in USD except per share items